Sifalimumab (Synonyms: MEDI-545; MDX 1103) |
| Katalog-Nr.GC69889 |
Sifalimumab (MEDI-545) is a monoclonal antibody against anti-IFNα, which inhibits abnormal immune activity by binding to multiple interferon-α subtypes. Sifalimumab can be used for research on systemic lupus erythematosus (SLE).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1006877-41-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Sifalimumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Sifalimumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *